COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,695 Articles (22,913 medRxiv, 8,782 bioRxiv)

Most recent first Previous |  Page 1257: Articles 12561-12570  | Next

Inequalities in COVID-19 inequalities research: who had the capacity to respond?
Benach, J., Padilla-Pozo, A., Rojas-Gualdron, D.-F., Cash-Gibson, L., Fernandez-Gracia, J., Eguiluz, V. M.
10.1101/2021.09.27.21264156 — Posted: 2021-09-29
How a positive COVID-19 diagnosis affects the physical, social and psychological wellbeing of people in the United Arab Emirates? An Explorative Qualitative Study
Alkuwaiti, M., Abu Hamda, B., Aljneibi, N., Silva Paulo, M., Elbarazi, I.
10.1101/2021.09.28.21264265 — Posted: 2021-09-29
Predictors of parents intention to vaccinate their children against the COVID-19 in Greece: a cross-sectional study
Galanis, P. A., Vraka, I., Siskou, O., Konstantakopoulou, O., Katsiroumpa, A., Moisoglou, I., Kaitelidou, D.
10.1101/2021.09.27.21264183 — Posted: 2021-09-29
Linguistic fairness in the U.S.: The case of multilingual public health information about COVID-19
Blasi, D. E., Mishra, V., Garcia, A. M., Dexter, J. P.
10.1101/2021.09.27.21264211 — Posted: 2021-09-29
World Science against COVID-19: Gender and Geographical Distribution of Research.
GONZALEZ-ALVAREZ, J.
10.1101/2021.09.29.21264261 — Posted: 2021-09-29
Counter-intuitive COVID-19 Trajectories - Explanations, Early Warning Indicator and Mitigation Strategies
Shayak, B., Sharma, M. M.
10.1101/2021.09.27.21264174 — Posted: 2021-09-29
Persistence of robust humoral immune response in COVID-19 convalescent individuals over 12 months after infection
Miyakawa, K., Kubo, S., Jeremiah, S. S., Go, H., Yamaoka, Y., Ohtake, N., Kato, H., Ikeda, S., Mihara, T., Matsuba, I., Sanno, N., Miyakawa, M., Shinkai, M., Miyazaki, T., Ogura, T., Ito, S., Kaneko, T., Yamamoto, K., Goto, A., Ryo, A.
10.1101/2021.09.27.21264013 — Posted: 2021-09-29
SARS-Cov-2 Infection versus Vaccine-Induced Immunity among Veterans
Young-Xu, Y., Smith, J., Korves, C.
10.1101/2021.09.27.21264194 — Posted: 2021-09-29 Discussion: Onsite
Mental Health Concerns Related to the COVID-19 Pandemic on Twitter in the UK
Zhang, D., Liu, Y., Zhang, S., Sun, L., Li, P., Anand, A., Xie, Z., Li, D.
10.1101/2021.09.27.21264177 — Posted: 2021-09-29
Monoclonal antibodies against SARS-CoV-2: potential game-changer still underused
Gentile, I., Maraolo, A. E., Buonomo, A. R., Nobile, M., Piscitelli, P., Miani, A., Schiano Moriello, N.
10.1101/2021.09.27.21264191 — Posted: 2021-09-29

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).